Walgreens Boots Alliance (WBA) Receives “Buy” Rating from Robert W. Baird

Robert W. Baird reiterated their buy rating on shares of Walgreens Boots Alliance (NASDAQ:WBA) in a report issued on Thursday. The firm currently has a $82.00 price objective on the pharmacy operator’s stock.

Other analysts have also issued research reports about the stock. Evercore ISI assumed coverage on shares of Walgreens Boots Alliance in a research note on Thursday. They issued an outperform rating and a $80.00 price objective on the stock. Loop Capital set a $90.00 price target on shares of Walgreens Boots Alliance and gave the stock a buy rating in a report on Thursday, October 26th. Royal Bank of Canada began coverage on shares of Walgreens Boots Alliance in a report on Tuesday, September 19th. They set an outperform rating and a $96.00 price target on the stock. Citigroup lowered their price target on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a buy rating on the stock in a report on Thursday, November 2nd. Finally, BidaskClub raised shares of Walgreens Boots Alliance from a strong sell rating to a sell rating in a report on Friday, November 10th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of Buy and an average price target of $86.05.

Shares of Walgreens Boots Alliance (WBA) traded up $1.32 during trading on Thursday, reaching $72.92. 6,265,753 shares of the company’s stock were exchanged, compared to its average volume of 8,735,833. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.07 and a quick ratio of 0.59. Walgreens Boots Alliance has a twelve month low of $63.82 and a twelve month high of $88.00. The firm has a market cap of $72,310.00, a price-to-earnings ratio of 20.14, a price-to-earnings-growth ratio of 1.35 and a beta of 1.22.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.24 by $0.04. The firm had revenue of $30.74 billion for the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The business’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.10 earnings per share. equities research analysts anticipate that Walgreens Boots Alliance will post 5.54 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.19%. The ex-dividend date of this dividend was Friday, November 10th. Walgreens Boots Alliance’s payout ratio is 44.20%.

Walgreens Boots Alliance declared that its board has initiated a stock buyback plan on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to purchase shares of its stock through open market purchases. Shares buyback plans are usually an indication that the company’s leadership believes its stock is undervalued.

In other Walgreens Boots Alliance news, Director John Anthony Lederer bought 20,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, October 26th. The stock was acquired at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the transaction, the director now directly owns 50,000 shares of the company’s stock, valued at $3,350,000. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director William C. Foote sold 2,736 shares of the stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the sale, the director now owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The disclosure for this sale can be found here. Company insiders own 14.80% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the company. Hudock Capital Group LLC increased its position in Walgreens Boots Alliance by 0.5% during the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 6 shares during the last quarter. Westside Investment Management Inc. increased its position in Walgreens Boots Alliance by 10.4% during the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 125 shares during the last quarter. Zions Bancorporation increased its position in Walgreens Boots Alliance by 983.3% during the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after purchasing an additional 1,239 shares during the last quarter. IHT Wealth Management LLC increased its position in Walgreens Boots Alliance by 46.3% during the second quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock worth $135,000 after purchasing an additional 2,199 shares during the last quarter. Finally, Bristlecone Advisors LLC acquired a new stake in Walgreens Boots Alliance during the third quarter worth about $135,000. Institutional investors and hedge funds own 61.18% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This report was first posted by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another domain, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this report can be accessed at https://www.tickerreport.com/banking-finance/3127351/walgreens-boots-alliance-wba-receives-buy-rating-from-robert-w-baird.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2018 Ticker Report. Google+.